Profound Medical Exceeds Q3 Revenue Outlook
Profound Medical (PROF) reported preliminary third-quarter revenue in the range of $9.8 million to $10.0 million, representing an 85%-89% year-over-year increase and a significant jump from its second quarter results by 292%-300%. The company's performance far exceeded the Bloomberg consensus estimate of $6.78 million. The revenue beat was accompanied by expectations that gross margin would exceed 70%, signaling strong cost control or pricing power in their operations. This positive financial update led to a surge in after-hours trading, as investors reacted favorably to the results and outlook for continued growth.
Topics: Gross Margin Guidance Revenue
Read the full article at Seeking Alpha
Part of the story Profound Medical Expects Q3 Revenue to Surpass Estimates by Nearly Half (3 articles)